Flora Growth acquires TruHC Pharma; TruHC audit shows going concern, minimal cash

ZeroStack Corp.

TruHC Pharma GmbH acquired; first closing completed April 23, 2024.
TruHC had €13.6K cash, €371.8K net loss for FY2023, cumulative deficit €588.7K.
Auditor issued going concern opinion; cash insufficient to meet obligations.
Q1 2024 unaudited statements show continued losses; pro forma combined financials filed.
Acquisition structure may strain Flora's liquidity; consideration not disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.